Biotechnology-powered haircare brand K18 announced the launch of FutureIQ, a biomimetic hair longevity serum to address shedding, early graying and scalp aging.
“Just as K18 molecular repair transformed how the world thinks about hair damage, FutureIQ longevity serum represents our vision for the future of hair aging,” said co-founder and chief executive officer Suveen Sahib. “The opportunity is to act earlier, supporting the biology that drives these changes before they accelerate. That shift from correction to preservation is what hair longevity is about, and we believe it represents the next frontier of haircare.”
According to the company’s press release, FutureIQ is powered by the brand’s proprietary MultiVital technology to provide oxidative defense, follicle anchoring, pigmentation and scalp resilience. The serum includes biomimetic peptides and advanced antioxidants that synergistically activate root proteins that hold hair in place. Clinical tests demonstrated up to 19,000 hairs retained, and 70% of participants showed fewer gray hairs after three months of nightly use.
“One of the biggest misconceptions about hair aging is that it begins when we first notice gray hair or thinning,” said Dr. Sheila Farhang, board-certified dermatologist and brand ambassador for K18. “In reality, biological changes inside the scalp and follicle, driven by oxidative stress, inflammation and environmental exposure, often begin years earlier. These processes are deeply interconnected which is why targeting a single visible symptom has historically fallen short. What makes FutureIQ longevity serum distinct is that it was designed to support those pathways simultaneously.”
FutureIQ biomimetic hair longevity serum will be available for purchase at select retailers beginning August 5, 2026.
